Sponsor bio page for STELFONTA® (tigilanol tiglate injection)

Bio

STELFONTA® (tigilanol tiglate injection) Important Safety Information

● Appropriate pre- and post-treatment medications must be given, including a corticosteroid plus blocking agents for both H1 and H2 receptors, in order to decrease the potential for severe systemic adverse reactions, including death, from mast cell degranulation.
● Accidental self-injection may cause severe wound formation

For more information, please go to: https://vet-us.virbac.com/stelfonta.